GlassScriptPhysician profile
Yolanda Prassada
NPI 1811008337
$2,357.70
in general payments reported to CMS, 2019-2025
18 companies · $759 in 2025
The $759 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $442 · 2023: $614 · 2024: $543 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,915.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $495.62 | 2022-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $396.54 | 2022-2025 | Slynd, Twirla |
| Astellas Pharma US INC | $271.01 | 2023-2025 | Veozah, Myrbetriq, Vesicare |
| Hologic Sales and Service, LLC | $253.59 | 2022-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $205.81 | 2022-2025 | |
| Shield Therapeutics INC | $149.88 | 2023-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $130.90 | 2023-2025 | |
| Abbvie INC. | $110.50 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $73.39 | 2025 | Myfembree |
| Alexion Pharmaceuticals, INC. | $47.14 | 2022-2023 | Ultomiris |
| Sage Therapeutics, LLC | $42.93 | 2022-2023 | |
| Minerva Surgical, INC | $36.78 | 2023 | |
| Millicent US INC | $32.21 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Amgen INC. | $28.79 | 2022-2024 | Evenity, Prolia |
| Myriad Women'S Health, INC. | $27.84 | 2023 | Myrisk |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $19.76 | 2024 | Twirla |
| Merck Sharp & Dohme LLC | $17.69 | 2023 | Gardasil 9 |
| Pfizer INC. | $17.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolanda Prassada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.